23andMe’s failure shows how risky it can be to invest in a SPAC
The bankruptcy underscores the great risks of investing in many of the companies that have gone public via mergers with ...
23andMe is potentially selling more than just genetic data. The personal survey info is also a privacy problem.
Me collected information from survey questions about personal health and beyond, such as drinking habits and risk tolerance.
DNA testing firm 23andMe files for bankruptcy as demand dries up
Me on Sunday filed for bankruptcy in the U.S. after struggling with weak demand for its ancestry testing kits and a 2023 data ...
23andMe files for bankruptcy, putting its hoard of personal health information at risk
23andme says it owns the aggregated genetic data of its customers, meaning it can sell it to the highest bidder ...
How to Delete Your 23andMe Data
Me is pursuing a sale after filing for bankruptcy, leading many customers to look into deleting their data from the company.
‘People should be worried’: 23andMe bankruptcy could expose customers’ genetic data
The direct-to-consumer DNA testing service 23andMe filed for bankruptcy earlier this month, putting millions of customers' ...
Meet Anne Wojcicki, the 23andMe founder who wants to bid on the company after stepping down as CEO
Anne Wojcicki has resigned as 23andMe's CEO. She is the sister of late YouTube CEO Susan Wojcicki and the ex-wife of Sergey ...
Yahoo Finance7d
23andMe’s failure shows how risky it can be to invest in a SPAC
23andMe bankruptcy underscores the risk of investing in most SPACs. - MarketWatch photo illustration/iStockphoto 23andMe is going bankrupt — underscoring the great ...
Morningstar7d
23andMe's failure shows how risky it can be to invest in a SPAC
Mergers with SPACs have been a way for companies to get public-market listings without the heavy scrutiny of the IPO process 23andMe is going bankrupt - underscoring the great risks of investing ...